Stock index futures ticked up on Tuesday, as the Senate voted to confirm Stephen Miran to the Federal Reserve’s board, just ahead of the central bank’s meeting to decide on the rate cut. Here are four stocks to keep an eye on:
Novo Nordisk (NVO) stock rose 2.7% in premarket trade as the firm is planning to submit regulatory filings to obtain FDA approval for a high-dose version of its blockbuster weight loss therapy Wegovy in the US. Earlier this year, the Danish drugmaker said that patients who received Wegovy at a higher dose of 7.2 mg experienced 21% weight loss over 72 weeks in a Phase 3 trial. This is compared to the 18% and 2% weight reduction seen in those who received regular Wegovy and placebo, respectively.
Rocket Lab (RKLB) shares fell 3.5% before the opening bell after the company entered into a $750 ATM equity offering with underwriters. The program allows the company to sell up to $750 million of its stock over time through several different investment banks, instead of all at once. The sales can happen over time and at market prices, giving Rocket Lab flexibility to raise money as needed.
Oracle (ORCL) was up 4.5% in premarket trade on a CBS report that it was part of a consortium looking to keep TikTok operating in the U.S. under a possible framework deal between China and the US. In this latest development, the deal’s precise structure remains unclear but will likely include a consortium of multiple companies.
Delta Air Lines (DAL) rose 0.5% before the market opens, as the Trump administration has ordered the firm and Aeromexico (AERO) to end their joint venture by January 1, 2026. The administration cited ongoing anticompetitive effects in the U.S.–Mexico City air travel market that have given both airlines an unfair advantage over competitors.